We are looking for children and teens 2–17 years of age to join a clinical trial to help us discover more about treating Crohn’s disease (CD). If you are looking for a potential new treatment option for Crohn’s disease (CD) or IBD (including associated symptoms such as fatigue, iron deficiency, bloody stool, weight loss and/or eye pain), consider one of our GI research studies. All eligible participants will receive no-cost study-related care and study medication. Your children and teens 2–17 years of age may be eligible to take part.
Your child may be eligible to take part in the GI research studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Enrollment is limited, so please respond now.
